# Xione Therapeutics, Inc. — Form D

Xione Therapeutics, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-12. The offering totals $200K, of which $90K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-08-12
- Form: D
- Accession: 0001784593-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $200K
- Amount sold: $90K
- Remaining: $110K
- Investors: 4
- Date of first sale: 2019-06-05
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-346356

## Issuer

- Name: Xione Therapeutics, Inc.
- CIK: 0001784593
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 2450 HOLCOMBE BOULEVARD., SUITE J, HOUSTON, TX, 77021
- Phone: 713-331-9443

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Eric J Devroe | Director | Cambridge, MA |
| Eric J Devroe | Executive Officer | Cambridge, MA |

## More

- [CIK 1784593 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1784593&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001784593-19-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.